Health & Fitness
Wed, June 2, 2010Tue, June 1, 2010Mon, May 31, 2010Sat, May 29, 2010Fri, May 28, 2010Thu, May 27, 2010Teva to Present at the UBS Global Specialty Pharmaceuticals Conference
//health-fitness.news-articles.net/content/2010/ .. global-specialty-pharmaceuticals-conference.html
Published in Health and Fitness on Monday, May 31st 2010 at 7:30 GMT by Market Wire🞛 This publication is a summary or evaluation of another publication
JERUSALEM--([ BUSINESS WIRE ])--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the UBS Global Specialty Pharmaceuticals Conference with Eyal Desheh, Teva's Chief Financial Officer, presenting on Wednesday, June 2, 2010 in London.
What: Teva's Presentation at the UBS Global Specialty Pharmaceuticals Conference
Who: Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries Ltd.
When: Wednesday, June 2, 2010 at 10:30 AM (local UK time)
Where:[ http://cc.talkpoint.com/ubsx001/060210a_ke/?entity=1_IWY155E ] or [ http://www.tevapharm.com/financial/ ]
How: Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.
About Teva
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 15 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Western Europe.